Active surveillance for low-grade appendiceal mucinous neoplasm (LAMN) [0.03%]
低级别阑尾黏液性肿瘤(LAMN)的主动监测
Christian Mouawad,Armelle Bardier,Mathilde Wagner et al.
Christian Mouawad et al.
Objectives: Due to the scarcity of low-grade appendiceal mucinous neoplasm (LAMN), there is an absence of systematized guidelines concerning its management, especially after incidental finding on an appendiceal specimen. ...
Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) [0.03%]
少见卵巢癌腹腔转移的细胞减灭术和腹腔热灌注化疗(CRS/HIPEC)治疗
Luis Felipe Falla-Zuniga,Armando Sardi,Mary Caitlin King et al.
Luis Felipe Falla-Zuniga et al.
Objectives: There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presenta...
Outcomes of minimal access cytoreductive surgery (M-CRS) and HIPEC/EPIC vs. open cytoreductive surgery (O-CRS) and HIPEC/EPIC in patients with peritoneal surface malignancies: a meta-analysis [0.03%]
微创细胞减灭术(M-CRS)和HIPEC/EPIC与开腹细胞减灭术(O-CRS)和HIPEC/EPIC治疗腹膜表面恶性肿瘤患者的预后差异：一项系统综述和meta分析
Ajinkya Pawar,Vikas Warikoo,Abhijeet Salunke et al.
Ajinkya Pawar et al.
Introduction: Minimal Access Surgery (MAS) has shown better peri-operative outcomes with equivalent oncological outcomes in gastrointestinal and thoracic oncology. Open CRS (O-CRS) procedure accompanies inevitable and sig...
Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP [0.03%]
服用达沙替尼治疗的CML-CP患者不会出现胸水伴发腹水的现象
Selin Küçükyurt,Tuğçe Eşkazan,Mesut Ayer et al.
Selin Küçükyurt et al.
Objectives: Pleural effusion (PE) is the most frequent pulmonary complication of dasatinib, a tyrosine kinase inhibitor (TKI). Concurrent pericardial effusions have been reported in about one-third of the cases. In this s...
Outcomes after curatively intended treatment of limited peritoneal metastases and thermal ablation for liver metastases from colorectal cancer [0.03%]
意图治愈的有限腹膜转移治疗和热消融治疗结直肠癌肝转移的效果研究
Rogini Balachandran,Mette Møller Sørensen,Jonas Amstrup Funder et al.
Rogini Balachandran et al.
Objectives: Peritoneal metastases (PM) and liver metastases (LM) are present simultaneously in up to 2 % of patients at the time of their colorectal cancer (CRC) diagnosis. Curatively intended treatment includes cytoreduc...
Michael Bau Mortensen,Francesco Casella,Özgül Düzgün et al.
Michael Bau Mortensen et al.
Objectives: To monitor the results of PIPAC directed therapy based on data from the International Society for the Study of the Pleura and Peritoneum (ISSPP) PIPAC database. ...
UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) with oxaliplatin for colorectal cancer peritoneal metastases (NCT03868228) [0.03%]
使用奥沙利铂对结直肠癌腹膜转移病人的加压腹腔内化疗（PIPAC）临床试验（NCT03868228）
Peter Kyle,Kitrick Perry,Anne Moutadjer et al.
Peter Kyle et al.
Objectives: This is the first UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for colorectal cancer peritoneal metastases. This trial aimed to assess the impact of PIPAC in combination with standa...
Genital cutaneous necrosis: a delayed sequela of intraperitoneal Mitomycin-c [0.03%]
皮肤坏死是腹腔内注射Mitomycin-c的一种后遗症
Sage A Vincent,Meghan Maceyko,Peter J Altshuler et al.
Sage A Vincent et al.
What is long-term survival in patients with peritoneal metastasis from gastric, pancreatic, or colorectal cancer? A study of patients treated with systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC) [0.03%]
胃癌，胰腺癌或结直肠癌发生腹膜转移后长期生存的定义：系统化疗和加压腹腔内喷雾化疗(PIPAC)治疗患者的观察研究
Charlotte G Kryh-Jensen,Claus W Fristrup,Alan P Ainsworth et al.
Charlotte G Kryh-Jensen et al.
Objectives: A definition of long-term survival (LTS) in patients with peritoneal metastasis (PM) from gastric cancer (GC), pancreatic cancer (PC) or colorectal cancer (CRC) treated with systemic chemotherapy and pressuriz...
Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model [0.03%]
腹腔热灌注化疗治疗结直肠癌腹膜转移的实验研究
Berke Manoğlu,Tuğba Yavuzşen,Safiye Aktaş et al.
Berke Manoğlu et al.
Objectives: In our study, we aimed to (1) create a peritoneal metastasis (PM) model in nude mice, administer intraperitoneal chemotherapy using the peritoneal infusion pump we developed in this model, and (2) compare the ...